5/15
11:50 am
arqt
Rating for ARQT
Medium
Report
Rating for ARQT
5/15
11:50 am
arqt
Rating for ARQT
Medium
Report
Rating for ARQT
5/15
07:08 am
arqt
Rating for ARQT
Medium
Report
Rating for ARQT
5/15
07:08 am
arqt
Rating for ARQT
Medium
Report
Rating for ARQT
4/12
08:00 am
arqt
Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $16.00 price target on the stock.
High
Report
Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $16.00 price target on the stock.
4/12
06:43 am
arqt
Rating for ARQT
High
Report
Rating for ARQT
4/12
06:43 am
arqt
Rating for ARQT
High
Report
Rating for ARQT